(Q34521994)

2 August 2017

1 reference

title

Low-dose ritonavir for protease inhibitor pharmacokinetic enhancement (English)

1 reference

2 August 2017

1 reference

1 reference

R Chris Rathbun

1

1 reference

2 August 2017

Deanna R Rossi

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

36

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

702-706

1 reference

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

2 August 2017

cites work

1 reference

Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg.

21 January 2018

1 reference

Dual protease inhibitor therapy in HIV-infected patients: pharmacologic rationale and clinical benefits

21 January 2018

1 reference

Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy

21 January 2018

1 reference

Dose-Finding Study of Once-Daily Indinavir/Ritonavir Plus Zidovudine and Lamivudine in HIV-Infected Patients

21 January 2018

1 reference

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults

21 January 2018

1 reference

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study

21 January 2018

1 reference

Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers

21 January 2018

1 reference

Interactions among drugs for HIV and opportunistic infections

21 January 2018

1 reference

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A202

1 reference

2 August 2017

1 reference